Jin et al. verified the effect of CXCR1 and CXCR2 in enhancing the migration and persistence of CAR-T cells in glioblastoma, ovarian cancer, and pancreatic cancer [53]. This evidence concerns the gene CXCR2 and ovarian carcinoma.